表紙
市場調査レポート

中国のビタミン産業におけるホットスポットの年間レビュー

Annual Review of Hot Spots in China's Vitamin Industry in 2014

発行 CCM 商品コード 324119
出版日 ページ情報 英文 15 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
中国のビタミン産業におけるホットスポットの年間レビュー Annual Review of Hot Spots in China's Vitamin Industry in 2014
出版日: 2015年01月09日 ページ情報: 英文 15 Pages
概要

当レポートでは、中国のビタミン産業におけるホットスポットについて調査分析し、背景、企業動向、ビタミンの市場価格の変動に焦点を当てて、市場予測も含めて、体系的な情報を提供しています。

第1章 サマリー

第2章 2014年1月以降、葉酸の市場価格は上昇傾向を維持

第3章 BASFドイツ工場で火災が発生

第4章 Garden Biochemicalがコレステロールの生産を一時中止

第5章 DSMがAland Nutraceuticalを買収

第6章 Xinfu Pharmaceuticalが子会社2社を合併

第7章 Haineng Bioengineeringが25-ヒドロキシビタミンD3を発売

第8章 Nansha LonzaのVB3の新生産ラインが稼動

図表

目次

On 19 March, 2014, BASF released a statement, explaining that its citral production line in Germany plant had suffered a fire and had to close down. BASF's total citral capacity accounts for more than 60% of the global capacity, thus the fire led to a tight supply of citral and had a huge impact on the downstream of vitamin A, fragrance and flavor, vitamin E and other products. However, even though BASF's citral resumed production as soon as in April 2014, the domestic supply situation didn't change quickly.

On 11 July, 2014, DSM announced that it had reached an agreement to acquire Aland Nutraceutical, a leading producer of vitamin C in China. Through the acquisition, DSM will be able to further strengthen its status in the vitamin C market and spread its domains all over the world in human nutrition and health care, animal nutrition and health care, and personal care.

On 25 Oct. 2014, Shandong Haineng Bioengineering Co., Ltd. conducted a "25-hydroxyvitamin D3" press conference in International Conference Center of Jinan City, Shandong Province. Haineng Bioengineering's launching 25-hydroxyvitamin D3 means that China is expected to break monopoly on technology and market dominated by foreign countries to some extent. And it speeds up the production and efficiency of livestock and poultry breeding.

Purpose of report:

In this report, CCM has analyzed hot spots in China's vitamin industry in 2014.

What to report:

In this report, hot spots in China's vitamin industry in 2014 have been analyzed exhaustively from the following aspects:

  • Background;
  • Company dynamics;
  • Market prices change of vitamins.

Forecasts:

In the next few years, the vitamin industry in China will continue to be promising. On the whole, it's worth investing in it.

Table of Contents

  • 1 Summary
  • 2 Market Price of Folic Acid Has Maintained Upward Trend Since Jan. 2014
  • 3 Fire Happened in Germany Plant of BASF
  • 4 Garden Biochemical Suspended Production of Cholesterol
  • 5 DSM Acquired Aland Nutraceutical
  • 6 Xinfu Pharmaceutical Combined Two Subsidiaries
  • 7 25-Hydroxyvitamin D3 Launched by Haineng Bioengineering
  • 8 New Production Line of VB3 in Nansha Lonza Launched

List of figures:

  • Figure 2-1 Market price of folic acid in China, Jan.-Nov., 2014
  • Figure 3-1 Market price of feed-grade VA in China, Jan.-Nov., 2014
  • Figure 4-1 Market price of feed-grade VD3 in China, Jan.- Nov., 2014
  • Figure 5-1 Market price of VC in China, Jan.-Nov., 2014
  • Figure 6-1 Market price of VB5 (Calcium pantothenate) in China, H2 2013-H1 2014
  • Figure 8-1 Market price of feed-grade VB3 in China, Jan. -Nov., 2014
Back to Top